Ixchelsis - Articles and news items

Ixchelsis announces positive Phase 2a results for IX-01

Industry news / 25 January 2016 / Victoria White

IX-01 is an oral oxytocin receptor antagonist being developed for the treatment of premature ejaculation…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+